Tofacitinib in the Treatment of Moderate-to-Severe Rheumatoid Arthritis in China: A Cost-Effectiveness Analysis Based on a Mapping Algorithm Derived from a Chinese Population - Tan, Chongqing; Li, Sini; Yi, Lidan; Zeng, Xiaohui; Peng, Liubao; Qin, Shuxia; Wang, Liting; Wan, Xiaomin (Advances in therapy, 2021)
Keywords: Cardiology; Endocrinology; Internal Medicine; Medicine; Medicine & Public Health; Oncology; Original Research; Pharmacology/Toxicology; Rheumatology; Model; Etanercept; Tofacitinib; Cost-effectiveness; Rheumatoid arthritis